Low VWF
Showing 1 - 25 of >10,000
Hemophilia A Trial in Japan, United States (Advate (Low Dose), Advate (High Dose), BIVV001 (Low Dose))
Completed
- Hemophilia A
- Advate (Low Dose)
- +3 more
-
Los Angeles, California
- +9 more
Mar 30, 2022
Low Von Willebrand Factor Trial in Milan (Whole-exome sequencing)
Recruiting
- Low Von Willebrand Factor
- Whole-exome sequencing
-
Milan, Lombardia, ItalyFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, A.B.
Mar 3, 2022
Low VW Activity in Adolescent HMB
Active, not recruiting
- Von Willebrand Factor Deficiency
- Genetic Analysis
- +3 more
-
Atlanta, Georgia
- +11 more
Apr 7, 2022
Platelet Mimicking Nanoparticles in Patients With Cirrhosis
Not yet recruiting
- Liver Cirrhosis
- Additional blood sampling at the same time and in addition of samplings already done for the patient's standard of care.
-
Villejuif, FranceAnaesthesia unit of the Hepatobiliary Center - Paul Brousse Hosp
Sep 18, 2023
Platelet Adhesion in the Pathobiology of Aortic Stenosis
Not yet recruiting
- Aortic Valve Stenosis
- Echocardiogaphy
-
Charlottesville, VirginiaUniversity of Virginia
Sep 19, 2022
Von Willebrand Diseases, Postpartum Hemorrhage Trial in Pittsburgh (Recombinant Von Willebrand factor, Tranexamic Acid Injection
Recruiting
- Von Willebrand Diseases
- Postpartum Hemorrhage
- Recombinant Von Willebrand factor
- Tranexamic Acid Injection [Cyklokapron]
-
Pittsburgh, Pennsylvania
- +1 more
Jul 5, 2022
Type 3 Von Willebrand International Registries Inhibitor
Active, not recruiting
- Type 3 Von Willebrand's Disease
- Von Willebrand Factor
-
Helsinki, Finland
- +24 more
Mar 21, 2022
Liver Cirrhosis, Spontaneous Bacterial Peritonitis Trial in New Delhi (20% High Dose Albumin, Standard Medical Treatment, 20%
Not yet recruiting
- Liver Cirrhosis
- Spontaneous Bacterial Peritonitis
- 20% High Dose Albumin
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Sep 8, 2023
Bleeding Disorder Trial in Charlottesville (Recombinant von Willebrand Factor)
Not yet recruiting
- Bleeding Disorder
- Recombinant von Willebrand Factor
-
Charlottesville, VirginiaUVA Hospital
Nov 3, 2023
Thrombotic Thrombocytopenic Purpura Trial (Aspirin tablet, Placebo)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Aspirin tablet
- Placebo
- (no location specified)
Sep 30, 2022
Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose
Recruiting
- Venous Thromboembolism
- Prophylactic low molecular weight heparin
- Low molecular weight heparin and low-dose aspirin
-
Toronto, Ontario, CanadaMount Sinai Hospital
Jan 18, 2023
Obstructive Sleep Apnea of Adult Trial in New York (Atorvastatin 10mg, Placebo, Continuous Positive Airway Pressure Therapy)
Recruiting
- Obstructive Sleep Apnea of Adult
- Atorvastatin 10mg
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Jan 25, 2023
Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Barotrauma
- Blood and bronchoalveolar fluid collection and analysis
- Chest CT scan
-
Cagliari, Italy
- +3 more
Aug 17, 2023
Hemostatic Profiles in Pediatric CKD
Active, not recruiting
- Kidney Disease, Chronic
- +3 more
- phlebotomy
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta - Egleston
Jul 19, 2022
Von Willebrand Disease (VWD) Trial (Recombinant von Willebrand Factor (rVWF), ADVATE)
Not yet recruiting
- Von Willebrand Disease (VWD)
- Recombinant von Willebrand Factor (rVWF)
- ADVATE
- (no location specified)
Oct 14, 2022
Pelvic Floor Disorders, Vaginal Atrophy Trial in Prague (vaginal laser treatment)
Active, not recruiting
- Pelvic Floor Disorders
- Vaginal Atrophy
- vaginal laser treatment
-
Prague, CzechiaInstitute for the care of mother and child
May 31, 2023
Diabetes, Type 2 Trial in Banja Luka (UDCA (Ursodeoxycholic acid), Placebo, Metformin)
Not yet recruiting
- Diabetes Mellitus, Type 2
- UDCA (Ursodeoxycholic acid)
- +2 more
-
Banja Luka, Republic Of Srpska, Bosnia and HerzegovinaPublic Health Institution Dom zdravlja Banja Luka
Jun 8, 2022
Hemophilia A Trial in Roma (SenseWear armband device)
Completed
- Hemophilia A
- SenseWear armband device
-
Roma, ItalyFPG
Mar 1, 2023
Von Willebrand Diseases, Hemophilia A Trial in Vienna (BT200)
Completed
- Von Willebrand Diseases
- Hemophilia A
-
Vienna, AustriaMedical University of Vienna
Nov 10, 2021
COPD, Emphysema, Emphysema or COPD Trial (dual anti-platelet therapy, Placebo)
Not yet recruiting
- COPD
- +2 more
- dual anti-platelet therapy
- Placebo
- (no location specified)
Oct 9, 2022
Von Willebrand Disease Trial (Alphanate SD/HT)
Active, not recruiting
- Von Willebrand Disease
- Alphanate SD/HT
- (no location specified)
May 5, 2022
Hemophilia A Trial in United States (Antihemophilic factor, recombinant, manufactured protein-free)
Completed
- Hemophilia A
- Antihemophilic factor, recombinant, manufactured protein-free
-
Little Rock, Arkansas
- +7 more
May 28, 2021
Type 1 Diabetes Trial in Milan (Medtronic MiniMed 780G with SmartGuard activation, Medtronic MiniMed 780G without SmartGuard
Recruiting
- Type 1 Diabetes
- Medtronic MiniMed 780G with SmartGuard activation
- Medtronic MiniMed 780G without SmartGuard activation
-
Milan, ItalyASST FBF Sacco
Jul 25, 2022
Endometriosis Trial in Boston (norethindrone acetate (NETA), Placebo)
Not yet recruiting
- Endometriosis
- norethindrone acetate (NETA)
- Placebo
-
Boston, MassachusettsBoston Children's Hospital
Sep 14, 2022